If the filing
person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box.
¨
|
|
|
|
|
|
|
1
|
|
Names of
reporting persons.
President and Fellows of Harvard College
|
2
|
|
Check the appropriate box if a member
of a group
(a)
¨
(b)
¨
|
3
|
|
SEC use only
|
4
|
|
Source of funds
WC
|
5
|
|
Check if disclosure of legal
proceedings is required pursuant to Items 2(d) or 2(e)
¨
|
6
|
|
Citizenship or place of
organization
Massachusetts
|
Number of
shares
beneficially
owned by
each
reporting
person
with
|
|
7
|
|
Sole voting power
0
|
|
8
|
|
Shared voting power
0
|
|
9
|
|
Sole dispositive power
0
|
|
10
|
|
Shared dispositive power
0
|
11
|
|
Aggregate amount beneficially owned by each reporting person
0
|
12
|
|
Check if the aggregate amount in Row
(11) excludes certain shares
¨
|
13
|
|
Percent of class represented by amount
in Row (11)
0.0%
|
14
|
|
Type of reporting person
EP
|
Item 1. Security and Issuer.
This statement on Schedule 13D relates to the shares of common stock, par value $0.01 per share (the Common Stock), of Maidenform
Brands, Inc., a Delaware corporation (the Issuer), which has its principal executive offices at 485F US Highway 1 South, Iselin, New Jersey 08830.
Item 2. Identity and Background.
This statement is filed by President and Fellows of Harvard College (Harvard), a Massachusetts educational corporation. The
principal executive offices of Harvard are located at c/o Harvard Management Company, Inc., 600 Atlantic Avenue, Boston, Massachusetts 02210. Harvards investment activities are carried on from the offices of Harvard Management Company, Inc. at
600 Atlantic Avenue, Boston, Massachusetts 02210.
Information relating to each of the President, the Fellows and the executive officers
of Harvard is contained in Exhibit A attached hereto and incorporated herein by reference. Each of the President, the Fellows and the executive officers of Harvard is a citizen of the Untied States of America.
None of Harvard or, to the best of Harvards knowledge or belief, any of the persons listed in Exhibit A has, during the past five years,
been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). Neither Harvard, nor to the best of Harvards knowledge and belief, any of the persons listed in Exhibit A has, during the past five years, been
party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or
Other Consideration.
Beneficial ownership of the Common Stock of the Issuer to which this statement relates was acquired by Harvard
with Harvards general funds.
Item 4. Purpose of Transaction.
This Amendment No. 1 to the Schedule 13D filed on September 13, 2013 is occasioned by Harvards disposition of shares of Common Stock, as
described in Item 5 below.
Harvard acquired the Common Stock in the ordinary course of its endowment investing for the purpose of
maximizing the risk-adjusted investment return on its endowment funds and other long-term investment assets. Except as described in previous filings on Schedule 13D, Harvard does not have any plans or proposals which relate to or would result in any
of the actions set forth in parts (a) through (j) of Item 4.
Item 5. Interest in Securities of the Issuer.
(a), (b) Harvard is the beneficial owner of 0 shares of Common Stock (0.0% of the shares of the Issuers issued and outstanding
Common Stock based on the most recent filing of the Issuer with the SEC).
(c) Since its most recent filing on Schedule 13D, Harvard not
bought or sold shares of Common Stock of the Issuer in open-market transactions on the New York Stock Exchange.
On October 7, 2013, the
Issuer consummated its acquisition by Hanesbrands Inc. (Hanesbrands) pursuant to the terms of that certain Agreement and Plan of Merger, dated as of July 23, 2013, by and among the Issuer, Hanesbrands and a wholly owned subsidiary of
Hanesbrands. Harvard received $23.50 per share in exchange for its 1,557,609 shares of Common Stock held at the time of the acquisition.
(d) Not applicable.
(e)
October 7, 2013.
Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.
Except as described in previous filings on Schedule 13D, Item 6 is not applicable.
Item 7. Material to be Filed as Exhibits.
|
|
|
Exhibit A
|
|
Information concerning the President, the Fellows and the executive officers of Harvard.
|
Signature
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true,
complete and correct.
|
|
|
|
|
|
|
|
|
Date: October 9, 2013
|
|
|
|
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Kathryn I. Murtagh
|
|
|
|
|
|
|
Name:
|
|
Kathryn I. Murtagh
|
|
|
|
|
|
|
Title:
|
|
Authorized Signatory
|
Exhibit Index
|
|
|
Exhibit
Number
|
|
Description
|
|
|
A
|
|
Information concerning the President, the Fellows and the executive officers of Harvard
|
Exhibit A
DIRECTORS AND EXECUTIVE OFFICERS
The names of the President,
the Fellows and the executive officers of Harvard and their business addresses and present principal occupation or employment are set forth below. If no business address is given, the business address of such director or executive officer is c/o
Harvard Management Company, Inc., 600 Atlantic Avenue, Boston, Massachusetts 02210.
PRESIDENT, FELLOWS AND EXECUTIVE OFFICERS OF HARVARD COLLEGE
|
|
|
Name
|
|
Office/Position
|
Drew Gilpin Faust
|
|
President
|
James F. Rothenberg
|
|
Treasurer
|
Mark Goodheart
|
|
Secretary
|
Lawrence S. Bacow
|
|
Fellow
|
James W. Breyer
|
|
Fellow
|
Paul J. Finnegan
|
|
Fellow
|
Susan L. Graham
|
|
Fellow
|
Nannerl O. Keohane
|
|
Fellow
|
William F. Lee
|
|
Fellow
|
Jessica T. Matthews
|
|
Fellow
|
Joseph J. ODonnell
|
|
Fellow
|
Robert D. Reischauer
|
|
Fellow
|
James F. Rothenberg
|
|
Fellow
|
Robert E. Rubin
|
|
Fellow
|
Theodore V. Wells Jr.
|
|
Fellow
|